Date Filed | Type | Description |
08/14/2020 |
GN
| Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value |
05/31/2011 |
BW
| ENZON Names Ana I. Stancic Chief Financial Officer |
05/19/2011 |
BW
| Enzon Announces Discontinuation of PEG-SN38 Program in Metastatic Colorectal Carcinoma in Light of Evolving Standards of Care |
05/06/2011 |
BW
| Enzon Reports 1st Quarter 2011 Results |
04/05/2011 |
BW
| Enzon Presents Data at 2011 AACR Meeting |
03/17/2011 |
BW
| Enzon Appoints Richard Mulligan, Ph.D. Vice-Chairman of the Board; Adopts Majority Vote Standard for Election of Directors |
02/17/2011 |
BW
| Enzon Reports 2010 Results |
02/10/2011 |
BW
| Enzon to Release Fourth Quarter 2010 Earnings on Thursday, February 17, 2011; Conference Call and Webcast to Follow |
12/15/2010 |
BW
| Enzon Announces the Initiation of Two Phase I Studies in Collaboration with the National Cancer Institute |
11/17/2010 |
BW
| Enzon Presents Data at 2010 EORTC-NCI-AACR Meeting |
11/02/2010 |
BW
| Enzon Reports Third Quarter 2010 Results |
11/02/2010 |
BW
| Enzon Pharmaceuticals Awarded $1.2 Million in Grants under QTDP Program |
10/29/2010 |
BW
| CORRECTING and REPLACING Abstracts Highlighting Data from Enzon's mRNA Antagonist Programs Accepted for Presentation at 2010 EORTC-NCI-AACR Meeting |
10/26/2010 |
BW
| Enzon to Release Third Quarter 2010 Earnings on Tuesday, November 2, 2010 |
07/28/2010 |
BW
| Enzon to Release Second Quarter 2010 Earnings on Tuesday, August 3, 2010; Conference Call and Webcast to Follow |
05/10/2010 |
BW
| Enzon Reports 1st Quarter 2010 Results |
05/07/2010 |
BW
| Enzon Sets Date of 2010 Annual Meeting |
05/06/2010 |
BW
| Enzon to Release First Quarter 2010 Earnings on Monday, May 10, 2010; Conference Call and Webcast to Follow |
04/22/2010 |
BW
| Enzon to Enhance Governance by Eliminating Board Classes |
04/21/2010 |
BW
| Enzon Presents Data at 2010 AACR Meeting |
04/13/2010 |
BW
| Enzon Will Present New Data on LNA and PEGylation Programs |
02/24/2010 |
BW
| Enzon Opens Pediatric Study of PEG-SN38 |
02/22/2010 |
BW
| Enzon Board of Directors Appoints Executive Committee |
02/17/2010 |
BW
| Enzon Reports 2009 Results |